GRPR antagonists for prostate cancer--prospects and caveats
- PMID: 23797339
- DOI: 10.1038/nrurol.2013.42-c1
GRPR antagonists for prostate cancer--prospects and caveats
Comment on
-
Targeting GRPR in urological cancers--from basic research to clinical application.Nat Rev Urol. 2013 Apr;10(4):235-44. doi: 10.1038/nrurol.2013.42. Epub 2013 Mar 19. Nat Rev Urol. 2013. PMID: 23507930 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
